Notably, a greater signal at the tumor site was seen with 7DC2-DyLight680 compared to 7DC4-DyLight680 (Figure 7A), further suggesting that 7DC2-VCMMAE is more stable and specific than 7DC4-VCMMAE in targeting CD47-expressing tumor tissues in mice. This evidence concerns the gene CD47 and neoplasm.